Anmeldung erfolgt in Kürze...
Details werden geladen...
Lilly deepens relationship with China’s Abbisko for $1.9B biobucks - BioSpace
Lilly has already spent more than $25 billion in potential business development commitments this year, including the $6.3 billion buyout of Centessa Pharmaceuticals that closed today.
Ähnliche Seiten
Regeneron deepens relationship with CytomX, adding up to $2B and eight targets - BioSpace
https://www.biospace.com/deals/regeneron-deepens-relationship-with-cytomx-adding-up-to-2b-and-eight-targetsLilly targets kidney disease with Ascidian’s RNA exon editors for up to $1.9B - BioSpace
https://www.biospace.com/deals/lilly-targets-kidney-disease-with-ascidians-rna-exon-editors-for-up-to-1-9b
Abbisko Therapeutics Deepens R&D Collaboration with Lilly | The Manila Times
https://www.manilatimes.net/2026/06/24/tmt-newswire/pr-newswire/abbisko-therapeutics-deepens-rd-collaboration-with-lilly/2371554